Drug Shortage Report for ONDANSETRON ODT
| Report ID | 212454 |
| Drug Identification Number | 02481723 |
| Brand name | ONDANSETRON ODT |
| Common or Proper name | ODANSETRON ODT |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | ONDANSETRON |
| Strength(s) | 4MG |
| Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
| Route of administration | ORAL ORAL |
| Packaging size | 10ODT |
| ATC code | A04AA |
| ATC description | ANTIEMETICS AND ANTINAUSEANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-12-04 |
| Estimated end date | 2024-01-26 |
| Actual end date | 2024-01-30 |
| Shortage status | Resolved |
| Updated date | 2024-01-31 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-01-31 | English | Compare |
| v5 | 2024-01-30 | French | Compare |
| v4 | 2024-01-30 | English | Compare |
| v3 | 2023-12-05 | English | Compare |
| v2 | 2023-12-04 | French | Compare |
| v1 | 2023-12-04 | English | Compare |
Showing 1 to 6 of 6